SCNXScienture Holdings Inc. Common Stock
0.4741USD+1.04%Mkt Cap: 19.47M $P/E:

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The …

Key Statistics

Company
Market Cap19.47M $
Enterprise Value11.19M $
Revenue (TTM)821.32K $
Gross Profit331.48K $
Net Income (TTM)-41.51M $
Revenue/Share0.0280 USD
Last Price0.4741 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISIN
Valuation
P/E (Trailing)
P/E (Forward)Infinity
PEG
EV/EBITDA-0.91
EV/Revenue13.62
P/S23.59
P/B0.30
EPS (TTM)-2.01
EPS (Forward)0.00
52W Range
0.238010% of range2.600
52W High2.600 USD
52W Low0.2380 USD
Profitability
Gross Margin76.80%
Oper. Margin-785.63%
EBITDA Margin0.00%
Profit Margin-9618.03%
ROE-59.20%
ROA-49.31%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-13.38M $
CapEx (TTM)
FCF Margin-335.41%
FCF Yield-14.15%
Net Debt-8.19M $
Net Debt/EBITDA0.66
Balance Sheet
Debt/Equity0.00
Current Ratio3.04
Quick Ratio2.83
Book Value/Sh1.561 USD
Cash/Share0.1990 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateJul 19, 2024
Pay DateJul 24, 2024
Splits
Last Split1:15
Split DateJun 22, 2023
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.500 USD
Upside (mean)+216.4%
Target Range1.500 USD1.500 USD
# Analysts1
Ownership
Shares Out.41.06M
Float33.14M
Insiders13.17%
Institutions5.30%
Short Interest
Short Ratio0.4d
Short % Float3.55%
Short % Out.3.30%
Shares Short1.34M
Short (prev mo.)935.99K
Technical
SMA 500.3880 (+22.2%)
SMA 2000.4527 (+4.7%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)4.24M
Avg Vol (10d)6.74M
Technical Indicators
RSI (14)69.8
MACD0.0225
MACD Signal0.0129
MACD Hist.+0.0096
BB Upper0.4794 USD
BB Middle0.4038 USD
BB Lower0.3283 USD
BB Width37.41%
ATR (14)0.0367 USD
Vol Ratio (20d)0.20x